HLA-E and renal cell carcinoma: These include a high frequency of the expression of immunomodulatory HLA-G and HLA-E [26–28, 33], a downregulation of HLA class Ia expression due to altered APM component expression and/or a deficient IFN-γ signaling of RCC cells [3, 34–36].